The Effect of Urea Nitrogen/Creatinin Ratio Level on in Hospital Mortality and One Year Mortality of Patients with ST Segment elevation Myocardial Infarction undergone thrombolytic therapy

Author:

Bodagh Haleh1,Yousefzadeh Asma1,Ghanivash Amin1,Banisefid Erfan1,Hamzezadeh Sina1,Moghadamziabari Seyedehyasmin2,Seifimansour Sina3,Khiavi Shila Mosadeghi1,Parizad Razieh1,Bodagh Mohammad bagher4

Affiliation:

1. Tabriz University of Medical Sciences

2. University of Davis

3. Ardabil University of Medical Sciences

4. Islamic Azad university, Tabriz, Iran.

Abstract

Abstract Introduction & Objective: Considering the increasing prevalence of ST-elevation myocardial infarction (STE-MI) and its health care costs and clinical consequences, as well as the fact that kidney problems are among the most common cases in these patients, treatment system and the evaluation of its functional improvement will be considered, Therefore, in the present study, we intend to investigate the effect of blood urea nitrogen to creatinin ratio (BUN/Cr) on in-hospital mortality (IHM) and one-year mortality of patients diagnosed with STEMI undergoing thrombolytic treatment. Materials and Methods: This descriptive cross-sectional descriptive study was conducted in in Shahid Madani, University of Medical Science, Tabriz, Iran in 2021. A list of patients diagnosed with STEMI and received thrombolytic treatments in 2017- 2019 were compiled. The file was included in the study and analyzed taking into account the inclusion and exclusion criteria. A checklist was used to collect the data. Data were analyzed using SPSS-15 software and descriptive and inferential statistics. Results: The results of the present study showed that blood BUN/Cr tolevel had no association with IHM and one-year mortality of STEMI patients who underwent thrombolytic treatment. There was also no association between the BUN/Cr ratio and in-hospital complications such as heart failure (HF) and cardiogenic shock (CS). Conclusion: we found that BUN/Cr ratio is not a reliable prognostic factor for mortality and hospital complications in STEMI patients.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3